00-27878. National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meetings  

  • Start Preamble

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings.

    The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, ZDK1 GRB 4 J2.

    Date: November 17, 2000.

    Time: 3 pm to 4 pm.

    Agenda: To review and evaluate grant applications.

    Place: 2 Democracy Plaza, 6707 Democracy Boulevard, 6th Floor, Room #647, Bethesda, MD 20892-5452 (Telephone Conference Call).

    Contact Person: William E. Elzinga, PhD, Scientific Review Administrator, Review Branch, DEA, NIDDK, Room 647, 6707 Democracy Boulevard, National Institutes of Health, Bethesda, MD 20892-6600 (301) 594-8895.

    Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel, ZDK1 GRB-7 J3.

    Date: November 19-20, 2000.

    Time: 7:30 pm to 5 pm.

    Agenda: To review and evaluate grant applications.

    Place: Hyatt Regency Hotel, One Bethesda Metro Center, Bethesda, MD 20814.

    Contact Person: Lakshmanan Sankaran, PhD, Scientific Review Administrator, Review Branch, DEA, NIDDK, Room 659, 6707 Democracy Boulevard, National Institutes of Health, Bethesda, MD 20892-6600 (301) 594-7799.

    Start Signature

    (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS)

    Dated: October 19, 2000.

    LaVerne Y. Stringfield,

    Director, Office of Federal Advisory Committee Policy.

    End Signature End Preamble

    [FR Doc. 00-27878 Filed 10-30-00; 8:45 am]

    BILLING CODE 4140-01-M

Document Information

Effective Date:
11/17/2000
Published:
10/31/2000
Department:
National Institutes of Health
Entry Type:
Notice
Document Number:
00-27878
Dates:
November 17, 2000.
Pages:
64976-64976 (1 pages)
PDF File:
00-27878.pdf